The Basel Area Life Sciences Supercluster is Europe’s most concentrated destination for biotech, pharma, healthtech and medtech innovation.
Basel, Switzerland
Joined May 2013
- Tweets4.9K
- Following700
- Followers1.9K
- Likes3.1K
BIIE aims to connect immune engineering research in the Basel Area with clinical partners around the world. In an interview with @BioPharmInt, Stephen Wilson, CEO of BIIE, shares how his institute plans to leverage the Basel Area to build global partnerships and advance its mission #supercluster #biotech
biopharminternational.com/vi…
How the right environment accelerates #biotech innovation. Our CEO Christof Klöpper explains @DDWJournal how ecoystems for biotech can advance innovation and why the Basel Area is an example of an impressive concentration of talent.
ddw-online.com/how-the-right…
Our CEO Christof Klöpper shares @BiotechTV the history of life sciences in Basel and describes the investments in infrastructure that have been made over recent years #supercluster #biotech
biotechtv.com/post/christof-…
Basel Area Life Sciences Supercluster retweeted
𝐅𝐫𝐨𝐦 𝐁𝐚𝐬𝐞𝐥: Christof Kloepper, CEO of Basel Area Business & Innovation, shares the history of life sciences in Basel and describes the investments in infrastructure that have been made over recent years.
Full video: biotechtv.com/post/christof-…
How can different technologies come together to advance immune engineering? In @BioPharmIntl, Stephen Wilson, CEO of BIIE, explains how the institute is building an integrated technology stack within the Basel Area #supercluster #biotech
biopharminternational.com/vi…
Basel Area Life Sciences Supercluster retweeted
𝐅𝐫𝐨𝐦 𝐁𝐚𝐬𝐞𝐥: Kicking off @ByAmyBrown's tour of Switzerland this week - today from Basel. Thanks to @BaselArea for making it possible.
Basel Area Life Sciences Supercluster retweeted
𝐅𝐫𝐨𝐦 𝐁𝐚𝐬𝐞𝐥: With two products on the market with momentum and a key pipeline asset in a P3, Basilea has become a world leader in the development of therapies for bacterial and fungal infections.
Full video: biotechtv.com/post/basilea-s…
Basel Area Life Sciences Supercluster retweeted
𝐅𝐫𝐨𝐦 𝐁𝐚𝐬𝐞𝐥: @BaseLaunch is designed to help early stage companies with resources that they might not have access to on their own.
Basel Area Life Sciences Supercluster retweeted
𝐅𝐫𝐨𝐦 𝐁𝐚𝐬𝐞𝐥: Forty51 Ventures was formed in Basel four years ago and has a company building model - they look globally, but believe that having the pharma company pipeline in Basel is an advantage. @baselarea
Full video: biotechtv.com/post/forty51ve…
Strong signal of the science moving from lab to launch in the Basel Area 🧬 Six life sciences startups from the Basel Area made the TOP 100 Swiss Startup Awards 2026 - with Aukera Therapeutics ranked the #1 biotech startup. Also named among the TOP 100: NXI Therapeutics, Mosanna Therapeutics, FimmCyte, Engimmune Therapeutics, @bottneuro #supercluster #biotech
top100startups.swiss/top-100…
Basel Area Life Sciences Supercluster retweeted
Translational research is driving progress in immune engineering as collaboration grows across academia and industry with @BaselArea. Hear insights from Dr Stephen Wilson, CEO, BIIE: hubs.li/Q04xbY_l0
#ImmuneEngineering #TranslationalResearch
How can an innovation ecosystem support a new immune engineering research institute? Stephen Wilson, CEO of BIIE, explains in @BioPharmIntl why the institute chose Basel for its new research facility. Basel’s concentrated ecosystem connects highly qualified local professionals with international scientists, universities, and global pharma. #supercluster #biotech
biopharminternational.com/vi…
Why should emerging biopharmaceutical companies consider market access and commercial factors earlier? How can the Basel Area’s concentration of cross-functional talent enhance product development and launch? In an interview with @BioPharmIntl, @khdetrick shares insights. #supercluster #biotech
biopharminternational.com/vi…
How does the Basel Area’s infrastructure help biopharma companies scale? In an interview with @BioPharmIntl, Senn Development CEO Johannes Eisenhut explores how flexible lab space, GMP-ready facilities, and academia-industry collaboration at the Main Campus of the @swissinnova Park Basel Area support companies from early-stage research to manufacturing scale-up. #Supercluster #LifeSciences
biopharminternational.com/vi…
Commercializing independently in Europe is becoming a real strategic option for emerging biotechs. Choosing the right ecosystem is part of the commercialization strategy. As @khdetrick writes @pharmaphorum: In the Basel Area, commercial talent and expertise across the launch journey are already within reach. #supercluster #biotech
pharmaphorum.com/market-acce…
Choosing the right lab location is increasingly about access to expertise and talent, strong networks for collaboration, and specialized laboratory infrastructure. @labdesignnews highlights the Basel Area as one of the world’s leading locations where companies can find all of this in one place. #supercluster #biotech
labdesignnews.com/content/wh…
As geopolitical shifts reshape R&D, manufacturing and supply networks, @JPluess from @swissinfo_en explores why the Basel Area is increasingly recognized alongside major pharma hubs such as Boston, Cambridge, and Leiden. #supercluster #biotech
swissinfo.ch/eng/healthcare-…
How is the Basel Area investing in the future of life sciences? As part of its interview series, @BioPharmIntl speaks with Johannes Eisenhut, CEO Senn Development, about how new research infrastructure and specialized talent are strengthening the region’s biopharma ecosystem - from startups to global players #supercluster #biotech
biopharminternational.com/vi…
In @BioPharmIntl, @khdetrick explains why talent and market access should be considered as the key factors much earlier in the expansion process - and why the Basel Area is the place to find that expertise #supercluster #biotech
biopharminternational.com/vi…
